Development and validation of a mobile application assisting oncologists with prescribing appropriate thromboprophylaxis for ambulatory cancer patients with high risk of thromboembolism — a pilot study
, 2, 3
Abstract
Introduction. Cancer significantly increases the risk of venous thromboembolism (VTE), with approximately one in five VTE events associated with malignancy. Although VTE can be prevented through appropriate prophylaxis, under-prophylaxis remains prevalent, particularly in Middle Eastern countries. Technology, particularly mobile applications, offers a promising solution for supporting decision-making in VTE management. This study aimed to develop a mobile application to assist oncologists in making informed decisions regarding thromboprophylaxis for ambulatory cancer patients.
Material and methods. The scientific content of the application was developed in accordance with the latest thromboprophylaxis guidelines and validated by a panel of three experts. For pilot testing of the application, it was given to all four oncologists working in the main oncology center at Al-Diwaniya Teaching Hospital. To assess the advantages and disadvantages of the application, each participant was asked to provide feedback using a 3-point Likert scale (good, fair, and poor).
Results. Three of the studied parameters received good ratings from all four participating oncologists (application’s ease of use, accuracy in detecting VTE risk, and recommending a suitable [safe] thromboprophylactic agent). Meanwhile, the other two parameters (reducing the time needed for assessing VTE risk and accuracy of deciding a suitable anticoagulant dose) were rated as good by 75% of participants and fair by 25% of participants.
Conclusions. The newly developed mobile application gained high acceptance from all oncologists at Al- Diwaniya Teaching Hospital. These oncologists considered the application an effective tool in supporting clinical decision-making and enhancing patient care in this critical area of oncology.
Keywords: mobile applicationvenous thromboembolismthromboprophylaxisambulatory cancer patientsIraq
References
- Khorana AA, Dalal M, Lin J, et al. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer. 2013; 119(3): 648–655.
- Khorana AA, Cohen AT, Carrier M, et al. Prevention of venous thromboembolism in ambulatory patients with cancer. ESMO Open. 2020; 5(6): e000948.
- Becattini C, Verso M, Muňoz A, et al. Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patients. Haematologica. 2020; 105(3): 838–848.
- Douce DR, Holmes CE, Cushman M, et al. Risk factors for cancer-associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE-PACC) study. J Thromb Haemost. 2019; 17(12): 2152–2159.
- Cella CA, Di Minno G, Carlomagno C, et al. Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study. Oncologist. 2017; 22(5): 601–608.
- Xin Z, Liu F, Du Y, et al. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients: a systematic review and network meta-analysis. Ann Palliat Med. 2020; 9(5): 2970–2981.
- Taner N, Şİrİn B. Evaluation of venous thromboembolism prophylaxis in cancer patients: a retrospective study. ACTA Pharmaceutica Sciencia. 2023; 61(2): 199.
- Awar Z, Sheikh-Taha M. Use of deep vein thrombosis prophylaxis in hospitalized cancer patients. Blood Coagul Fibrinolysis. 2009; 20(7): 571–574.
- Tariq M, Mikhael E. Venous Thromboembolism Risk Assessment Among Ambulatory Cancer Patients: Demographic Study and Doctor's Adherence to Guidelines. Al- Anbar Medical Journal. 2024; 0(0): 0–0.
- Naeemah G, Ameen A. Assessment of adherence to National Comprehensive Cancer Network guideline recommended anticoagulant therapy in the management of patients with cancer-associated venous thromboembolic disease. Maaen Journal for Medical Sciences. 2023; 2(3).
- Tariq MA, Mikhael EM. Determining the perceptions and practices of oncologists regarding venous thromboembolism risk assessment in ambulatory cancer patients: A qualitative study. PLoS One. 2025; 20(1): e0316801.
- Pillet A, Minne F, Belhadj Chaidi R, et al. Management of venous thromboembolism in cancer patients according to guidelines after educative measures. Bull Cancer. 2018; 105(5): 486–492.
- Alhilali DN. Venous Thromboembolism Risk and Prophylaxis in Hospitalized Patients in Iraq. Journal of Pharm. and Biomed. Sci. 2016; 6.
- Kang CY, Duncan GJ, Clements DH, et al. The Roles of Transfer of Learning and Forgetting in the Persistence and Fadeout of Early Childhood Mathematics Interventions. J Educ Psychol. 2019; 111(4): 590–603.
- Bertsche T, Nachbar M, Fiederling J, et al. Assessment of a computerised decision support system for allergic rhino-conjunctivitis counselling in German pharmacy. Int J Clin Pharm. 2012; 34(1): 17–22.
- Mikhael EM, Al-Hamadani FY, Hadi AM. Design and evaluation of a new mobile application to improve the management of minor ailments: a pilot study. BMC Health Serv Res. 2022; 22(1): 920.
- Streiff MB, Holmstrom B, Angelini D, et al. Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021; 19(10): 1181–1201.
- British National Formulary. BNF 85: March-September 2023. London: Pharmaceutical Press; 2023. 1904 p.
- Chisholm-Burns MA, Schwinghammer TL, Malone PM, et al. Pharmacotherapy: Principles & Practice. 6th ed. New York. ; 2022.
- Mikhael EM, Hassali MA, Hussain SA. Validation of newly developed culturally specific diabetes self-management education and support program for Iraqi type 2 diabetes mellitus patients. J Educ Health Promot. 2021; 10: 357.
- Azami G, Soh K, Sazlina SG, et al. Developing and Validating the Educational Materials for a Nurse-Led Self-Management Education in Adults with Type 2 Diabetes. Dubai Diabetes and Endocrinology Journal. 2019; 25(1-2): 1–10.
- Aungst TDy. Medical applications for pharmacists using mobile devices. Ann Pharmacother. 2013; 47(7-8): 1088–1095.
- Divall P, Camosso-Stefinovic J, Baker R. The use of personal digital assistants in clinical decision making by health care professionals: a systematic review. Health Informatics J. 2013; 19(1): 16–28.
- Payne KF, Wharrad H, Watts K. Smartphone and medical related App use among medical students and junior doctors in the United Kingdom (UK): a regional survey. BMC Med Inform Decis Mak. 2012; 12: 121.
- Berkowitz CM, Zullig LL, Koontz BF, et al. Prescribing an App? Oncology Providers' Views on Mobile Health Apps for Cancer Care. JCO Clin Cancer Inform. 2017; 1: 1–7.
- Mosa AS, Yoo I, Sheets L. A systematic review of healthcare applications for smartphones. BMC Med Inform Decis Mak. 2012; 12: 67.
- Mikhael E. Evaluating the Benefits of Using Mobile Application (diarrhea management step by step) in the Management of Diarrhea by Community Pharmacists. Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512). 2023; 32(1): 245–256.
- Martínez-Pérez B, de la Torre-Díez I, López-Coronado M, et al. Mobile clinical decision support systems and applications: a literature and commercial review. J Med Syst. 2014; 38(1): 4.
- Vanstone M, Monteiro S, Colvin E, et al. Experienced physician descriptions of intuition in clinical reasoning: a typology. Diagnosis (Berl). 2019; 6(3): 259–268.